ArticleBriefings in bioinformatics2025
Denoising spatially resolved transcriptomics with consistency of heterogeneous spatial coordinates, transcription, and morphology.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- SpaDiff denoises sequence-based spatial transcriptomics via diffusion process.Cell reports methods · 2026Article
- Deep Learning-Assisted Prioritization of Candidate Drug Targets in Tumors Using Spatial Multi-Omics.Biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Spatially resolved transcriptomics (SRT) simultaneously captures spatial coordinates, pathological features, and transcriptional profiles of cells within intact tissues, offering unprecedented opportunities to explore tissue architecture. However, SRT data often suffer from substantial technical noise introduced by experimental procedures, posing challenges for downstream analyses. To overcome these challenges, we introduce a Multiview Denoising framework for Spatial Transcriptomics (MvDST), which integrates a deep autoencoder and self-supervised learning to jointly reconstruct expression profiles, denoise features, and enforce cross-view consistency, effectively reducing technical noise, and heterogeneity. As a result, MvDST reliably and accurately delineates tissue subgroups across simulated datasets under various perturbations. In real cancer datasets, it distinguishes tumor-associated domains, identifies region-specific marker genes, and reveals intra-tumoral heterogeneity. Furthermore, we validate the robustness of MvDST across multiple spatial transcriptomics platforms, including 10 $\times $ Visium, STARmap, and osmFISH. Overall, these results demonstrate that MvDST can serve as a crucial initial step for the analysis of spatially resolved transcriptomics data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.